pitchbook.com Open in urlscan Pro
34.110.234.203  Public Scan

Submitted URL: https://url6380.news.pitchbook.com/ls/click?upn=-2B0Jlug6i80mluh5Xp2-2BZsfdSR-2BbC0M2D2Pkba6hdCexEZchbkBxCmkQgblVPhk7jykHDH3HN54AkD...
Effective URL: https://pitchbook.com/profiles/investor/11263-51
Submission: On May 08 via api from US — Scanned from DE

Form analysis 1 forms found in the DOM

/profiles/search

<form action="/profiles/search" class="search-form search-form_focused float-right-XL align-right" role="search" __bizdiag="113" __biza="WJ__">
  <input type="text" name="q" value="" maxlength="200" aria-label="Search" class="search-form__input" placeholder="Search profile previews">
  <button type="submit" aria-label="Search button" role="button" class="btn-search search-form__submit"></button>
  <span data-btn-search-collapsed="" class="XL-0 d-block-XS icon-profile-close secondary-text search-form__close px-xl-10 py-xl-5"></span>
</form>

Text Content

 * Request a free trial Log in
 * Products
 * Solutions
 * Data
 * News & Analysis
 * About
 * Blog

Log in Request a free trial


ORBIMED



This is a profile preview from the PitchBook Platform.

Request a free trial
 * Overview
 * Investments
 * Exits
 * Fund Performance
 * Limited Partners
 * Lead Partners on Deals
 * Investments Analytics
 * Team
 * Board Members
 * Service Providers
 * Investment Preferences


ORBIMED OVERVIEW

Update this profile
 * Investor Type


 * PE/ BUYOUT

 * Status


 * ACTIVE

 * Professionals


 * 69


 * Investments


 * 827

 * Portfolio


 * 231

 * Exits


 * 388




ORBIMED GENERAL INFORMATION

Description

Founded in 1989, OrbiMed is a private equity firm based in New York, New York.
The firm prefers to invest through means of buyouts and growth capital. The firm
prefers to invest in the biopharmaceutical, life sciences, digital health,
healthcare services, medical devices, and diagnostic sectors based in Asia,
Europe, North America, and Israel region.


CONTACT INFORMATION

Website
www.orbimed.com
Year Founded
1989
Investor Status
Actively Seeking New Investments
Primary Investor Type
PE/Buyout
Other Investor Types
Asset Manager
Growth/Expansion
Hedge Fund
Venture Capital
Primary Office
 * 601 Lexington Avenue (at 53rd Street)
 * 54th Floor
 * New York, NY 10022-4629
 * United States

+1 (212) 000-0000





ORBIMED INVESTMENTS & ACQUISITIONS (827)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
0000000000 0000000 03-May-2023 00000 00000 0000 Biotechnology Pre-Clinical
Trials 000 0000 00.0 0000000 0000000 03-May-2023 00000 00000 0000 Therapeutic
Devices Clinical Trials - General 00000 000000 00 000 000000000000 13-Apr-2023
00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 00000000000
10-Apr-2023 00 000000000 Medical Supplies Generating Revenue 00000 000000 00
Harpoon Therapeutics 27-Mar-2023 PIPE 0000 Drug Discovery Generating Revenue/Not
Profitable

You’re viewing 5 of 827 investments and acquisitions. Get the full list »


WANT DETAILED DATA ON 3M+ COMPANIES?

What you see here scratches the surface

Request a free trial


WANT TO DIG INTO THIS PROFILE?

We’ll help you find what you need

Learn more


ORBIMED EXITS (388)

Company Name Exit Date Exit Type Exit Size 0000000000 26-Mar-2023 0000000 000000
00000 0000000 000000 20-Mar-2023 000000000000000000 0000000 0000000000
23-Feb-2023 0000000 000000 0000000 000000000 22-Feb-2023 000000000000000000 0000
Tricida 11-Jan-2023 Bankruptcy: Admin/Reorg

You’re viewing 5 of 388 exits. Get the full list »


ORBIMED FUND PERFORMANCE

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore OrbiMed‘s
full profile, request access.

Request a free trial



ORBIMED INVESTMENTS BY INDUSTRY, YEAR, AND REGION

Investments by Industry



Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical
investments—showing a breakdown of activity by industry, year and region.

Request a free trial



ORBIMED TEAM (149)

Name Title Deals Funds Boards Office Trey Block Chief Financial Officer New
York, NY Daniel Rhee Chief Technology Officer New York, NY David Wang Ph.D
Partner & Senior Managing Director 00 0 0 Shanghai, China Sunny Sharma MD
Partner & Senior Managing Director, Asia 00 0 0 Mumbai, India Steven Wang Ph.D
Partner & Senior Managing Director, Asia 0 0 New York, NY

You’re viewing 5 of 149 team members. Get the full list »
Products
 * PitchBook Desktop
 * PitchBook Mobile
 * CRM Integration
 * Excel Plugin
 * Chrome Extension
 * Direct Data
 * Institutional Research Group
 * Morningstar Institutional Equity Research
 * Product Releases

PitchBook for

 * Private Market Valuations
 * Venture Capital
 * Private Equity
 * Hedge Funds
 * Startups

Profile Previews
Solutions
 * Private Market Intel
 * Fundraising
 * Deal Sourcing
 * Due Diligence
 * Business Development
 * Networking
 * Deal Execution
 * Benchmarking
 * Asset Allocation

Blog Webinars Video Library
Data
 * Companies
 * Investors
 * Deals
 * M&A
 * Limited Partners
 * Funds
 * Financials
 * Advisors
 * Professionals
 * Debt
 * Lenders
 * Data Operations

Leveraged Commentary and Data
News & analysis
 * Reports
 * Newsletter
 * Advertise
 * Research & Analysis Team

About
 * Customer Success
 * Client Testimonials
 * What Sets Us Apart
 * Press Inquiries
 * Partnerships
 * Careers

Follow us

 * 
 * 
 * 
 * 
 * 

US Headquarters

 * +1 (206) 623.1986
 * 901 Fifth Avenue
 * Suite 1200
 * Seattle, WA 98164

European Headquarters

 * +44 (0) 20 8037.2308
 * 1st Floor Saffron House
 * 6-10 Kirby Street
 * London EC1N 8TS
 * United Kingdom

Asia-Pacific Headquarters

 * 80 Raffles Place
 * #41-01 UOB Plaza 1
 * Singapore 048624

Contact Us
 * info@pitchbook.com
 * Request Research
 * Profile Request
 * Deal Submission
 * GDPR Compliance

Follow us

 * 
 * 
 * 
 * 
 * 

© 2023 PitchBook. Win what’s next. All rights reserved.

 * Terms of Use
 * Privacy Policy




We need your consent to proceed to PitchBook
Our site uses cookies and other technologies to improve your experience and
understand how you and other visitors use our site.
You can configure your preferences at any time using the cookie policy tool.
When you access our site, the companies listed in our cookie policy will use
cookies on our site.
Agree and Enter
Close  ✖